Study Feasibility
Operational risk starts long before First Patient In (FPI), and it doesn’t stop once enrollment begins.
Medidata Study Feasibility brings together AI-powered forecasting, Diversity Analytics, and Performance Analytics in one unified solution.
Design, Execute, and Adapt with Confidence
You’re expected to deliver faster enrollment, stronger diversity representation, and predictable timelines—without increasing complexity or cost. But too often, feasibility decisions rely on incomplete data and static forecasts.
Medidata Study Feasibility gives you evidence you can act on.
Model timelines, optimize site selection, set evidence-based diversity goals, and continuously benchmark live performance against industry trends.
Standardized, Cross-industry Clinical Trial Data
Site-level Operational Performance Metrics
Actionable, Real-time Insights
Turnkey White Glove Support
Medidata Study Feasibility Outcomes
Optimized Protocols
Design Operationally Feasible Studies
Medidata Protocol Optimization uses AI-driven modeling to simulate trial performance before First Patient In, helping you assess patient burden, site performance, and trial cost early.
That visibility helps reduce amendments, prevent enrollment delays, and improve trial efficiency.
FAQ
How does Medidata Study Feasibility improve site selection accuracy?
The solution uses AI-powered forecasting derived from actual site-level enrollment and congestion data—not just surveys—to identify high-performing sites. It provides unmatched granularity on operational performance metrics, including enrollments, screen failures, and data quality, allowing you to select sites that are statistically more likely to meet your specific timeline goals.
What data foundation supports the feasibility insights?
Medidata leverages the industry’s largest proprietary dataset, comprising over 38,000 trials and 12 million patients across 140+ countries. Additionally, the data is refreshed weekly from over 8,000 active studies, ensuring that your feasibility assessments and benchmarks are based on relevant, real-time industry performance rather than outdated historical records.
Can the solution assist with meeting diversity enrollment targets?
Yes. The platform allows you to identify sites with a proven historical track record of recruiting diverse patient populations. By using indication-specific, cross-industry patient demographic data, you can prioritize sites that consistently meet diversity goals, helping you achieve inclusivity targets and comply with regulatory Diversity Action Plans.
Does the platform help mitigate enrollment risks during the study?
Yes. Beyond initial planning, the solution offers "Live Study Forecasting" which allows you to track your study against industry benchmarks in real-time. This capability helps clinical operations teams detect enrollment slowdowns or risks early, allowing for immediate course correction to keep timelines on track.
Does Medidata offer training for its clients and partners?
Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.